MARCHETTI, ANDREA

MARCHETTI, ANDREA  

Borsisti  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.082 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa...; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco 2022-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer Nuvola, Giacomo; Santoni, Matteo; Rizzo, Mimma; Rosellini, Matteo; Mollica, Veronica; Rizzo, Ales...sandro; Marchetti, Andrea; Battelli, Nicola; Massari, Francesco 2023-01-01 EXPERT REVIEW OF ANTICANCER THERAPY - 1.01 Articolo in rivista -
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study Rizzo A.; Mollica V.; Marchetti A.; Nuvola G.; Rosellini M.; Tassinari E.; Molina-Cerrillo J.; My...int Z.W.; Buchler T.; Monteiro F.S.M.; Grande E.; Santoni M.; Massari F. 2022-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2022 [MOUSEION04].pdfcancers-14-04142-s001.zip
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt Mollica V.; Marchetti A.; Rosellini M.; Nuvola G.; Rizzo A.; Santoni M.; Cimadamore A.; Montironi... R.; Massari F. 2021-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-22-13519-v2.pdf
An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma Marchetti A.; Rosellini M.; Rizzo A.; Mollica V.; Battelli N.; Massari F.; Santoni M. 2021-01-01 EXPERT OPINION ON PHARMACOTHERAPY - 1.01 Articolo in rivista -
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Tateo, Valentina; Nuvola, Giacomo; Rizzo,... Alessandro; Massari, Francesco; Mollica, Veronica 2023-01-01 EXPERT OPINION ON DRUG SAFETY - 1.01 Articolo in rivista -
Bone targeting agents in patients with metastatic prostate cancer: State of the art Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucc...i C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F. 2021-01-01 CANCERS - 1.01 Articolo in rivista Cancers 2021 [Bone Mets].pdf
Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw Mollica V.; Nuvola G.; Tassinari E.; Nigro M.C.; Marchetti A.; Rosellini M.; Rizzo A.; Errani C.;... Massari F. 2022-01-01 CURRENT ONCOLOGY - 1.01 Articolo in rivista Current Oncology 2022 [Bone agents PCa].pdf
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis Rosellini, Matteo; Mollica, Veronica; Marchetti, Andrea; Coluccelli, Sara; Giunchi, Francesca; Ta...ssinari, Elisa; Ricci, Costantino; Fiorentino, Michelangelo; Tallini, Giovanni; De Biase, Dario; Massari, Francesco 2024-01-01 PATHOLOGY, RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Clinical outcomes and prognostic factors in patients with penile carcinoma: a sub-analysis from Meet-URO 23 (I-RARE) registry study Mollica, Veronica; Massari, Francesco; Maruzzo, Marco; Bimbatti, Davide; Claps, Melanie; Maiorano..., Brigida Anna; Vitale, Maria Giuseppa; Iacovelli, Roberto; Ermacora, Paola; Roviello, Giandomenico; Calabrò, Fabio; Caffo, Orazio; Vignani, Francesca; Grillone, Francesco; Pierantoni, Francesco; Napoli, Marilena Di; Mennitto, Alessia; Marchetti, Andrea; Mattana, Alvise; Cavo, Alessia; Bassanelli, Maria; Formisano, Luigi; Prati, Veronica; Giudice, Giulia Claire; Buti, Sebastiano 2024-01-01 CLINICAL GENITOURINARY CANCER - 1.01 Articolo in rivista -
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Mo...ntironi R.; Ardizzoni A.; Massari F. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchet...ti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier; Grande, Enrique; Battelli, Nicola; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma Mollica V.; Santoni M.; Matrana M.R.; Basso U.; De Giorgi U.; Rizzo A.; Maruzzo M.; Marchetti A.;... Rosellini M.; Bleve S.; Maslov D.; Tawagi K.; Philon E.; Blake Z.; Massari F. 2022-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista -
Current androgen receptor antagonists under investigation for resistant prostate cancer Nigro M.C.; Mollica V.; Marchetti A.; Cheng M.; Rosellini M.; Montironi R.; Cheng L.; Massari F. 2022-01-01 EXPERT REVIEW OF ANTICANCER THERAPY - 1.01 Articolo in rivista -
Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: A critical overview of recent evidence Rizzo A.; Rosellini M.; Marchetti A.; Mollica V.; Massari F. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials Rizzo, Alessandro; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Ricci, Angela Dalia; ...Fiorentino, Michelangelo; Battelli, Nicola; Santoni, Matteo; Massari, Francesco 2021-01-01 PATHOLOGY RESEARCH AND PRACTICE - 1.01 Articolo in rivista -
Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer Rosellini M.; Marchetti A.; Tassinari E.; Nuvola G.; Rizzo A.; Santoni M.; Mollica V.; Massari F. 2022-01-01 EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT - 1.01 Articolo in rivista -
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, C...ostantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco 2023-01-01 MOLECULAR DIAGNOSIS & THERAPY - 1.01 Articolo in rivista Molecular Diagn Ther 2023 [Neoadj UC].pdf
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study Rizzo, Alessandro; Mollica, Veronica; Tateo, Valentina; Tassinari, Elisa; Marchetti, Andrea; Rose...llini, Matteo; De Luca, Raffaele; Santoni, Matteo; Massari, Francesco 2023-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysis Rizzo, Alessandro; Nuvola, Giacomo; Palmiotti, Gennaro; Ahcene-Djaballah, Selma; Mollica, Veronic...a; Rosellini, Matteo; Marchetti, Andrea; Nigro, Maria Concetta; Tassinari, Elisa; Macrini, Sveva; Massari, Francesco 2023-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -